Literature DB >> 32479234

The Growth Of Private Equity Investment In Health Care: Perspectives From Ophthalmology.

Eloise May O'Donnell1, Gary Joseph Lelli2, Sami Bhidya3, Lawrence P Casalino4.   

Abstract

The growth of private equity investment in health care has dramatically changed the landscape of health care delivery over the past decade. Private equity firms are rapidly acquiring physician practices, with ophthalmology practices being one of the most frequently acquired types. We present perspectives from thirty-five semistructured interviews conducted with a wide range of knowledgeable people on private equity investment in physician practices, with a specific focus on ophthalmology. Acquisition by a private equity firm can be an attractive option for physicians, particularly older ones. However, interviewees had starkly conflicting perspectives on the likely impact of private equity acquisitions on the cost, quality, and use of medical care.

Entities:  

Keywords:  Access and use; Access to care; Costs and spending; Drug use; Health care consolidation; Health policy; Markets; Medicine; Ophthalmology; Organization of care; Pharmaceuticals; Physician practices; Physicians; Private equity acquisition; Private equity investment; Quality Of Care; Surgery

Mesh:

Year:  2020        PMID: 32479234     DOI: 10.1377/hlthaff.2019.01419

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

1.  Private equity and its effect on patients: a window into the future.

Authors:  Sajith Matthews; Renato Roxas
Journal:  Int J Health Econ Manag       Date:  2022-05-23

2.  Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization.

Authors:  Yashaswini Singh; Zirui Song; Daniel Polsky; Joseph D Bruch; Jane M Zhu
Journal:  JAMA Health Forum       Date:  2022-09-02

3.  Changes in Hospital Income, Use, and Quality Associated With Private Equity Acquisition.

Authors:  Joseph D Bruch; Suhas Gondi; Zirui Song
Journal:  JAMA Intern Med       Date:  2020-11-01       Impact factor: 44.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.